Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus by Zili Hu, Zili Hu, Zhenyun Yang, Zhenyun Yang, Jiongliang Wang, Jiongliang Wang, Yizhen Fu, Yizhen Fu, Zhiwen Hu, Zhiwen Hu, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang

Connect to this object online.

Survival benefit of preoperative hepatic arterial infusion of oxaliplatin, fluorouracil, and leucovorin followed by hepatectomy for hepatocellular carcinoma by Zili Hu, Zili Hu, Zhenyun Yang, Zhenyun Yang, Yangxun Pan, Yangxun Pan, Yizhen Fu, Yizhen Fu, Jiongliang Wang, Jiongliang Wang, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Dandan Hu, Dandan Hu, Yaojun Zhang, Yaojun Zhang

Connect to this object online.

Comparison of hepatic arterial infusion chemotherapy with mFOLFOX vs. first-line systemic chemotherapy in patients with unresectable intrahepatic cholangiocarcinoma by Zhenyun Yang, Zhenyun Yang, Yizhen Fu, Yizhen Fu, Weijie Wu, Weijie Wu, Zili Hu, Zili Hu, Yangxun Pan, Yangxun Pan, Juncheng Wang, Juncheng Wang, Jinbin Chen, Jinbin Chen, Dandan Hu, Dandan Hu, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang

Connect to this object online.